Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03848884 · ClinicalTrials.gov registry record · NA
Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction
A NA study of Adherence, Patient, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT03848884: Completed NA study of Adherence, Patient, sponsored by Virginia Commonwealth University.
NCT03848884 is a NA study of Adherence, Patient that has completed, run by Virginia Commonwealth University. The registered enrollment target is 34 participants, below the 750-participant average among 11 other Adherence, Patient trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03848884, a NA study of Adherence, Patient, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?
Primary Outcome
Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.
Conditions Studied
Interventions
- BEHAVIORAL Adherence monitoring and education
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2019-10-16 |
| Phase | NA |
What the finished NCT03848884 record still lists
NCT03848884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 750-participant average among 11 other Adherence, Patient trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Adherence, Patient appearing as the primary indexed condition, and to 1 intervention - of which Adherence monitoring and education is the first listed.
NCT03848884 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03848884 about?
NCT03848884 is a clinical study titled "Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction". Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?
What is the current status of trial NCT03848884?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-03-01. Estimated completion is 2019-10-16.
What conditions does trial NCT03848884 study?
This clinical trial studies the following conditions: Adherence, Patient.
What interventions are being tested in trial NCT03848884?
The interventions under investigation include: Adherence monitoring and education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03848884?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03848884 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adherence, Patient
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03848884's enrollment target sits among peer trials
34 11th of 11 higher than 1 of 11 other Adherence, Patient trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adherence, Patient trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
RECRUITING · NA
-
Culturally Tailored HPV Psychoeducational Multimedia Intervention
RECRUITING · NA
-
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
ACTIVE NOT RECRUITING · NA
-
A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
ACTIVE NOT RECRUITING · NA
-
Increasing Adherence to Lung Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Postcards to Improve Remote Monitoring Adherence Among Veterans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI